TTRX - NASDAQ

Turn Therapeutics Inc.

TTRX·NASDAQ

$6.42

+1.1%

HealthcareBiotechnology

Global Health Solutions, Inc., doing business as Turn Therapeutics, operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. Global Health Solutions, Inc. was incorporated in 2015 and is based in Westlake Village, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$191.24M

EPS-0.2300

P/E Ratio-16.95

Earnings Date09/02/2026

ttrx

Operating Expenses

Last Annual Value

5.86M

3-Year CAGR

36%

5-Year CAGR

20%

10-Year CAGR

10%

Adjust for Inflation

Turn Therapeutics Inc. Competitors Analysis of Operating Expenses

TTRX · NASDAQ

Company	Operating Expenses	CAGR 3Y	CAGR 5Y	CAGR 10Y
Turn Therapeutics Inc. NASDAQ:TTRX	5.86M	36.4%	N/A	N/A
Tevogen Bio Holdings Inc. NASDAQ:TVGN	53.16M	84.5%	63.0%	N/A
Greenwich LifeSciences, Inc. NASDAQ:GLSI	19.45M	27.7%	33.4%	N/A
Actuate Therapeutics Inc NASDAQ:ACTU	22.50M	-3.4%	N/A	N/A
Alto Neuroscience, Inc. NYSE:ANRO	65.70M	20.2%	40.2%	N/A
C4 Therapeutics, Inc. NASDAQ:CCCC	132.46M	-4.5%	0.7%	N/A
Cardiff Oncology, Inc. NASDAQ:CRDF	48.65M	2.0%	10.7%	2.5%
Nuvectis Pharma, Inc. NASDAQ:NVCT	27.57M	6.4%	16.4%	N/A
PepGen Inc. NASDAQ:PEPG	92.22M	3.3%	27.7%	N/A
Seer, Inc. NASDAQ:SEER	86.46M	-6.7%	3.9%	N/A
TuHURA Biosciences, Inc. NASDAQ:HURA	31.80M	55.9%	7.0%	14.4%

Turn Therapeutics Inc. Fair Value Envelope

TTRX · NASDAQ

Our analysis suggests that TTRX has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $6.42, this represents a potential HIDDEN relative to our calculated worth for Turn Therapeutics Inc..

HIDDEN

Intrinsic Value

Current Price: $6.42

Related Guides

Blog Categories

Continue your TTRX research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.